Venture Visionary Partners LLC Gsk PLC Transaction History

Venture Visionary Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$42.05 - $47.77 $27,248 - $30,954	-648 Reduced 8.78%	6,730 $298,000
Q1 2022 May 03, 2022	BUY	$40.23 - $47.74 $24,741 - $29,360	615 Added 9.09%	7,378 $321,000
Q4 2021 Feb 08, 2022	SELL	$38.88 - $45.31 $9,720 - $11,327	-250 Reduced 3.56%	6,763 $324,000
Q3 2021 Oct 20, 2021	SELL	$38.79 - $43.16 $2,288 - $2,546	-59 Reduced 0.83%	7,013 $267,000
Q2 2021 Aug 05, 2021	SELL	$36.52 - $41.46 $146,591 - $166,420	-4,014 Reduced 36.21%	7,072 $281,000
Q1 2021 Apr 27, 2021	BUY	$34.27 - $40.01 $44,413 - $51,852	1,296 Added 13.24%	11,086 $395,000
Q4 2020 Jan 27, 2021	BUY	$34.07 - $39.94 $333,545 - $391,012	9,790 New	9,790 $360,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Venture Visionary Partners LLC with notifications on news.